Abiraterone Acetate Tablets USP 500 mg — Class II drug recall D-0074-2027
Ongoing recall by Glenmark Pharmaceuticals Inc., USA, reported 2026-11-04, distributed nationwide. Labeling: Not Elsewhere Classified
| Recall number | D-0074-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ, United States |
| Recall initiated | 2026-10-09 |
| Classified | 2026-10-23 |
| Reported by FDA | 2026-11-04 |
| Distributed | Nationwide (US) |
| Quantity | 1,296 bottles |
| Reason classes | labeling |
| NDC | 68462-0135, 68462-0135-08, 68462-0882, 68462-0882-60 |
| Lot numbers | 13250135 |
| Expiration dates | 2027-11 |
Product
Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC 68462-882-60
Reason for recall
Labeling: Not Elsewhere Classified
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0074-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.